Article Details

Advancements in AntiCD40L Monoclonal Antibodies Promising Future for TNX1500 and Frexalimab

Retrieved on: 2024-03-05 14:23:05

Tags for this article:

Click the tags to see associated articles and topics

Advancements in AntiCD40L Monoclonal Antibodies Promising Future for TNX1500 and Frexalimab. View article details on HISWAI: https://beststocks.com/advancements-in-anticd40l-monoclonal-antibodi/

Excerpt

Tonix Pharmaceuticals has recently reported encouraging findings on TNX-1500, a cutting-edge third-generation anti-CD40L monoclonal antibody (mAb) ...

Article found on: beststocks.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up